Skip to content

Anxiety on the First Day of Chemotherapy

The Effect of Art Design in the Chemotherapy Waiting Room on the Anxiety of Patients Who Will Receive Chemotherapy for the First Time

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04839835
Enrollment
106
Registered
2021-04-09
Start date
2020-11-01
Completion date
2022-03-03
Last updated
2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Breast Cancer

Brief summary

investigating chemotherapy anxieties

Detailed description

Breast cancer is the most common type of cancer in women in the world, and it is the first in cancer-related deaths in women all over the world. In the treatment of breast cancer, in addition to surgery, patients with advanced stage or high risk of recurrence receive neoadjuvant and adjuvant chemotherapy treatments. This period starts with 3 months and extends according to the treatment protocols it will receive. Since the first diagnosis of breast cancer, it has psychological effects such as intense stress, decrease in quality of life and anxiety as well as physical effects on patients. The time spent in the waiting room while patients are examined and receiving treatment before chemotherapy inevitably has an effect on their anxiety. In this study; It was aimed to investigate the effects of environmental factors in waiting rooms on patients' anxiety.

Interventions

OTHERwaiting room enriched with music, paintings and artificial plants

waiting room enriched with music, paintings and artificial plants

Sponsors

Namik Kemal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* to receive chemotherapy for breast cancer for the first time * give consent for the study

Exclusion criteria

* not approving to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
anxiety and stress measurements60-120 minutesThe State-Trait Anxiety Inventory (STAI) - Measuring anxiety with the Hospital Anxiety and Depression Scale (HADS)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026